↓ Skip to main content

The Role of V-Domain Ig Suppressor of T Cell Activation (VISTA) in Cancer Therapy: Lessons Learned and the Road Ahead

Overview of attention for article published in Frontiers in immunology, May 2021
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
39 Dimensions

Readers on

mendeley
41 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The Role of V-Domain Ig Suppressor of T Cell Activation (VISTA) in Cancer Therapy: Lessons Learned and the Road Ahead
Published in
Frontiers in immunology, May 2021
DOI 10.3389/fimmu.2021.676181
Pubmed ID
Authors

Negar Hosseinkhani, Afshin Derakhshani, Abdoli Shadbad, Antonella Argentiero, Vito Racanelli, Tohid Kazemi, Ahad Mokhtarzadeh, Oronzo Brunetti, Nicola Silvestris, Behzad Baradaran

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 41 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 41 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 6 15%
Other 4 10%
Student > Ph. D. Student 4 10%
Student > Bachelor 4 10%
Student > Master 2 5%
Other 3 7%
Unknown 18 44%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 9 22%
Medicine and Dentistry 3 7%
Immunology and Microbiology 3 7%
Engineering 2 5%
Business, Management and Accounting 1 2%
Other 5 12%
Unknown 18 44%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 May 2021.
All research outputs
#23,487,873
of 26,163,973 outputs
Outputs from Frontiers in immunology
#28,334
of 33,001 outputs
Outputs of similar age
#397,199
of 461,733 outputs
Outputs of similar age from Frontiers in immunology
#1,194
of 1,393 outputs
Altmetric has tracked 26,163,973 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 33,001 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.5. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 461,733 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,393 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.